EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for ADGM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -0.3024
March 31, 2026 -0.3149
December 31, 2025 -0.1641
September 30, 2025 -0.6578
June 30, 2025 -0.3494
March 31, 2025 -0.5016
December 31, 2024 -3.775
September 30, 2024 -0.3185
June 30, 2024 -6.441
March 31, 2024 -10.28
December 31, 2023 -0.28
Date Value
September 30, 2023 -14.15
June 30, 2023 -10.42
March 31, 2023 -12.25
December 31, 2022 1.562
September 30, 2022 0.0294
June 30, 2022 -0.0102
March 31, 2022 -0.011
December 31, 2021 -0.0571
September 30, 2021 -0.2655
June 30, 2021 -0.0085
March 31, 2021 -0.011

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.2735
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832
Baxter International, Inc. 0.2432

EPS Diluted (Quarterly) Related Metrics